SwedenLivingWorldBusinessSportsEntertainment

Nanexa

Nanexa signs SEK 13 billion licensing deal with Novo Nordisk
Business News

Nanexa signs SEK 13 billion licensing deal with Novo Nordisk

Swedish pharmaceutical company Nanexa has entered into a licensing and collaboration agreement with Danish giant Novo worth just over SEK 13 billion, according to a press release.
Show Consent Options

Categories

Information

Sweden Herald

  • Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
  • © Sweden Herald